Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib

We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate patients with desmoid tumors undergoing therapy with imatinib. The study included 22 patients with progressive disease (PD) of a biopsy proven desmoid tumor treated orally with imatinib 800 mg daily. Pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kasper, Bernd, Dimitrakopoulou-Strauss, Antonia, Pilz, Lothar R., Strauss, Ludwig G., Sachpekidis, Christos, Hohenberger, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671300/
https://ncbi.nlm.nih.gov/pubmed/23762842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/389672
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares